Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that combining iron supplements with physiotherapy improved hair condition and growth in women with iron deficiency-related telogen hair loss compared to iron supplements alone.

PRP therapy can regrow 30%-40% of lost hair in 3 months without side effects.

This study found that feeding sheep rations with up to 30% Leucaena leucocephala leaf meal did not significantly affect mimosine concentrations or alter blood metabolites and thyroid hormones, suggesting it can be used without detrimental effects in these aspects.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

This study found that among women with diffuse hair loss, 26.2% had a history of drug intake, with antihypertensives being the most common drug group implicated.

Stem cell treatment improved hair density in female hair loss patient.

This study reported that AA-PRP injections significantly increased hair count and density in individuals with pattern hair loss compared to baseline, demonstrating their potential for enhancing hair growth.

This review outlines a systematic method for diagnosing hair loss and presents no new findings; the authors emphasize the importance of biopsy in cicatricial alopecia cases.

This review discusses the possible link between prediabetes and hair loss, highlighting the need for further studies to evaluate this relationship and suggesting screenings for diabetes in patients with hair loss.

This study found that patients with alopecia areata had a higher frequency of the AB+ blood group compared to healthy controls.

This case report identified a 4-month-old boy with Menkes disease, a neurodegenerative disorder of copper metabolism, noting symptoms like recurrent seizures, developmental delay, and specific physical characteristics, confirmed by genetic sequencing showing a pathogenic ATP7A mutation and low serum copper and ceruloplasmin levels.

This study reported that alopecia in giant pandas may be linked to abnormal expression of several hair-related genes and pathways, providing insight for potential prevention and treatment strategies.

This review discusses the potential of stem cell therapies for regenerating hair in nonautoimmune hair loss and calls for more studies to evaluate their efficacy.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

This study evaluated the safety and effectiveness of MNC-QQ cell therapy in five men with androgenic alopecia, reporting no adverse effects and improvements in hair growth, hair density, and quality of life over six months.

This research highlights the lack of clinical evidence linking GLP-1 agonists, commonly used in treating type 2 diabetes and obesity, to hair loss, despite theoretical concerns regarding potential hair health impacts.

This study examined the knowledge and training needs of pharmacy staff in Crimea regarding hair loss counseling, finding that despite frequent patient inquiries, many staff feel underprepared and express a desire for further educational courses to improve their ability to advise on alopecia treatment options.

In this study, researchers will conduct a randomized, double-blind, multi-center clinical trial to assess the effectiveness of YH0618 granule in preventing chemotherapy-induced hair loss among breast cancer patients, aiming to understand its mechanism related to kidney deficiency in Chinese Medicine. Results are not yet reported.

This study reviews various causes of hair loss in midlife women, emphasizing the importance of accurate diagnosis due to the overlapping features of different types of alopecia and suggesting a comprehensive approach that includes detailed history, scalp examination, and sometimes biopsies or blood tests.

This study found that female pattern hair loss in Saudi women was associated with lower hematological parameters and serum ferritin levels, suggesting iron deficiency may contribute to the disease.

This article discusses the historic use of oral minoxidil for severe hypertension and the subsequent development of a topical formulation for treating pattern hair loss, but reports no new results.

Genetics and hormones cause hair loss; finasteride treats it safely.

This review discusses possible medication-induced hair loss and the need to exclude other confounding factors like stress and illness; it reports no new clinical findings and emphasizes careful assessment before attributing hair loss to medications.

This study found that human umbilical cord blood mesenchymal stem cells promoted hair growth by advancing anagen onset and increasing hair follicle regeneration in an in vivo model.

This report describes two cases of stroke associated with finasteride use for male-pattern hair loss, suggesting a potential link to thrombosis due to increased estrone and estradiol levels.

This case report describes a 37-year-old woman whose recurrent hair shedding was associated with low iron stores and a miscarriage, with improvements seen after increased iron intake.

The study observed unexpected blue fluorescence in urine linked to salicylate metabolite presence, suggesting "aspirin addiction" in patients with unexplained hair loss, potentially tied to chronic disease or hair production interference.

In this study, the ABO/Rh blood group distribution in individuals with polycystic ovary syndrome was similar to that of healthy individuals, and there was no link with clinical or biochemical factors of PCOS.

This report describes a case where a woman's hair loss following COVID-19 vaccination improved after treatment with autologous CD34+ hematopoietic progenitor cells and umbilical cord blood-derived mesenchymal stem cells, with no significant adverse effects observed over the 12-week treatment period.

This study developed consensus guidelines for the use of low-dose oral and topical minoxidil in male and female pattern hair loss, recommending specific doses, monitoring procedures, and timing of application around hair transplant surgeries.